LDH release assays revealed that CAR-NK-92 cells exhibited enhanced killing ability against EpCAM-positive colorectal cancer cells at various E:T ratios of 40:1, 20:1, 10:1, 5:1, and 1:1. Here, EPCAM is linked to colorectal cancer.